Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms
Not Applicable
Completed
- Conditions
- Unruptured Intracranial Aneurysms
- Interventions
- Other: diffusion-weighted MRI and clinical examination
- Registration Number
- NCT02862756
- Lead Sponsor
- CHU de Reims
- Brief Summary
Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.
- Detailed Description
In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
- patient having a programmed endovascular treatment for unruptured intracranial aneurysm
- patient older than 18 years
- patient consenting to participate to the study
- patient enrolled in the national healthcare insurance program
Exclusion Criteria
- patients with contraindications for MRI
- patients whose clinical condition does not allow sufficient cooperation to the realization of MRI
- patients with arteriovenous malformation intracranial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description patient with endovascular treatment diffusion-weighted MRI and clinical examination -
- Primary Outcome Measures
Name Time Method Thromboembolic complication 72 hours after endovascular treatment Thromboembolic complication diagnosed using diffusion-weighted MRI
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu de Reims
🇫🇷Reims, France